Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine
 Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Location: United States, MO

Trial Information

Midwest Chest Consultants, located in St. Charles Missouri, is currently conducting a research study with individuals with Chronic Obstructive Pulmonary Disease (COPD).

The study can last up to 58 weeks and can require up to 8 office visits and one follow-up telephone call. At each visit, the safety and effectiveness of the study medication will be monitored. Additionally, compensation for time and travel may be provided.

Patient Inclusion Criteria:

  • Are at least 40 years of age.
  • Have been diagnosed with COPD
  • Have experienced at least two COPD exacerbations (flare-ups) within the previous 12 months that caused you to seek medical attention.
  • Are a current or former smoker

Patient Exclusion Criteria:

  • Current diagnosis of asthma
  • History of suicidal behavior within the last two years.
  • Morbid Obesity
  • Alcohol or drug abuse within the last five years
  • History (within the last 5 years) or current diagnosis of cancer

Mitchell Champagne RPh, CCRC, Research Director
Midwest Chest Consultants, PC
330 First Capitol Drive
Suite 470
St. Charles, MO 63301
Phone: 636-946-1650
Email: research@midwestchest.com

View Map

Research Center Information: Midwest Chest Consultants, PC

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.